RISK FACTOR ANALYSIS IN RENAL TRANSPLANTATION: GUIDELINES FOR THE MANAGEMENT OF THE TRANSPLANT RECIPIENTFINKELSTEIN FO; BLACK HR.1974; AMER. J. MED. SCI.; U.S.A.; DA. 1974; VOL. 267; NO 3; PP. 159-169; BIBL. 22 REF.Article

PSYCHIATRIC COMPLICATIONS OF ANTIHYPERTENSIVE MEDICATIONSPOTTASH ALC; BLACK HR; GOLD MS et al.1981; J. NERV. MENT. DIS.; ISSN 0022-3018; USA; DA. 1981; VOL. 169; NO 7; PP. 430-438; BIBL. 108 REF.Article

EFFECT OF HEAVY CIGARETTE SMOKING ON RENAL AND MYOCARDIAL ARTERIOLESBLACK HR; ZEEVI GR; SILTEN RM et al.1983; NEPHRON; ISSN 0028-2766; CHE; DA. 1983; VOL. 34; NO 3; PP. 173-179; BIBL. 30 REF.Article

CEFAMANDOLE: IN VITRO AND CLINICAL PHARMACOKINETICS.GRIFFITH RS; BLACK HR; BRIER GL et al.1976; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1976; VOL. 10; NO 5; PP. 814-823; BIBL. 12 REF.Article

RENOVASCULAR HYPERTENSION PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENTBLACK HR; GLICKMAN MG; SCHIFF M JR et al.1978; YALE J. BIOL. MED.; USA; DA. 1978; VOL. 51; NO 6; PP. 635-654; BIBL. 95 REF.Article

PHARMACOLOGY OF CINOXACIN IN HUMANSBLACK HR; ISRAEL KS; WOLEN RL et al.1979; ANTIMICROB. AGENTS CHEMOTHERAPY; USA; DA. 1979; VOL. 15; NO 2; PP. 165-170; BIBL. 17 REF.Article

PARTITION OF CINOXACIN AND NALIDIXIC ACID IN CANINE VASCULAR AND EXTRAVASCULAR COMPARTMENTSSZWED JJ; REDLICH LR; ELLIOTT RA et al.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 8; PP. 567-568; BIBL. 6 REF.Article

CINOXACIN: PHARMACOKINETICS AND THE EFFECT OF PROBENECIDISRAEL KS; BLACK HR; NELSON RL et al.1978; J. CLIN. PHARMACOL.; USA; DA. 1978; VOL. 18; NO 10; PP. 491-499; BIBL. 10 REF.Article